Drug Topics

OCTOBER 24, 2022

According to NEXGEL, the patch is expected be available for ophthalmologists to offer to their patients in the first half of 2023.

464

464

PharmaVoice

OCTOBER 24, 2022

Why a ‘very exciting’ trial of the therapy in lupus patients could swing the door open to new studies in autoimmune diseases.

203

203

Drug Topics

OCTOBER 24, 2022

Turn your pharmacy into a point-of-care testing site.

360

360

PharmaVoice

OCTOBER 24, 2022

In Amgen's 2022 Biosimilars Trend Report, the company tracks the progress and potential of the copycat drugs as they reach a pivotal moment.

203

203

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

OCTOBER 24, 2022

Flip the Pharmacy helped this Jonesboro, Arkansas, pharmacy go from a traditional dispensing one to a pharmacy offering robust clinical services.

360

360

PhRMA

OCTOBER 24, 2022

The bipartisan Bayh-Dole Act created a framework for researchers receiving federal funds to patent and license their inventions to companies for further development and commercialization. This benefits innovators across many sectors.

201

201

PharmaVoice

OCTOBER 24, 2022

In a recent study, 50% of healthcare consumers reported that a bad digital experience with their provider ruined the entire experience, while 39% felt that a good digital interaction had a positive influence.

187

187

Drug Topics

OCTOBER 24, 2022

Jerry Meece, RPh, CDCES, FACA, FADCES, initiates a discussion around the increasing prevalence of patients diagnosed with diabetes.

190

190

Pharmacy Times

OCTOBER 24, 2022

Jacinda Abdul-Mutakabbir, PharmD, discusses the difference between the original SARS-CoV-2 strain and subvariant strains.

121

121

Drug Store News

OCTOBER 24, 2022

A celebration of business for Fruth Pharmacy is also a celebration of the life of Jack Fruth and his gifts to the local communities which it continues to serve.

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

OCTOBER 24, 2022

Researchers conducted a review all 8 herpesviruses and their known treatments and found patients experienced encephalitis or another CNS symptom in almost every strain.

115

115

Drug Store News

OCTOBER 24, 2022

Project Watson’s products were formulated to help support dogs’ eyes, ears and overall well-being, the company said.

98

98

Pharmacy Times

OCTOBER 24, 2022

A researcher suggests that the levels of certain gut bacteria can predict the severity of symptoms that someone can experience when infected with COVID-19.

111

111

Drug Store News

OCTOBER 24, 2022

Free delivery will help accelerate access to COVID-19 treatment for underserved U.S. populations, Walgreens said.

98

98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

OCTOBER 24, 2022

The test has been available under emergency use authorization (EUA) since March of 2020 and was the first commercial molecular test to receive EUA status.

FDA 107

FDA 107

Drug Store News

OCTOBER 24, 2022

Tree Hut’s Holidaze collection features holiday-centric Shea Sugar Scrubs, as well as a Whipped Body Butter and Bare Moisturizing Shave Oil.

98

98

Pharmacy Times

OCTOBER 24, 2022

Black adults are suggested to have an increased risk of heart failure, which highlights the need for equitable treatment and decision-making.

101

101

Drug Store News

OCTOBER 24, 2022

In time for the holidays, customers will be able to place an order using Venmo as their payment method on Amazon.com and the Amazon mobile app.

97

97

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

ISPE

OCTOBER 24, 2022

A Resurgence in Plasma: Trends in The Industry. Trudy Patterson. Mon, 10/24/2022 - 14:57. iSpeak Blog. iSpeak. A Resurgence in Plasma: Trends in The Industry. Eduardo Munoz, PE. 24 October 2022. Global demand for plasma-derived therapies (PDTs) continues to swell—the compacting result of an aging population, clinical successes, and recent applications for both widespread diseases and multiple rare conditions.

Immunization 95

Immunization 95

Drug Store News

OCTOBER 24, 2022

The test kits are available at CVS Health locations and at CVS.com.

96

96

Pharmacy Times

OCTOBER 24, 2022

Automation can lessen the administrative burden on providers and accelerate specialty prescribing and dispensing to provide patients with quality care the moment they need it.

94

94

STAT

OCTOBER 24, 2022

It’s quite the task to photograph someone’s heart while they’re exercising. They have to lie on their back in a pressure-controlled chamber, riding a suspended stationary bike while an ultrasound imager points at their pumping heart — at least that’s how one group of researchers from the University of Calgary and Hong Kong went about it.

86

86

Pharmacy Times

OCTOBER 24, 2022

An ASCP 2022 session presenter explains some recent updates on vaccination guidance for the older adult population.

Vaccines 94

Vaccines 94

STAT

OCTOBER 24, 2022

On, December 9, 2020, my mom, brother, and I waited in a cold, wintery drizzle outside the local hospital in my hometown in southern Colorado, anxiously hoping to be allowed to see my dad for the last time. After contracting Covid-19, he had been in the intensive care unit (ICU) for nearly a month and his condition had deteriorated to the point that we were summoned to the hospital to say our goodbyes.

Hospitals 86

Hospitals 86

Pharmacy Times

OCTOBER 24, 2022

The approval includes a novel dose and schedule of the combination, with a single dose of both drugs followed by durvalumab every 4 weeks in patients with unresectable hepatocellular carcinoma.

FDA 94

FDA 94

PharmExec

OCTOBER 24, 2022

Rocket Pharmaceutical's CEO and CTO spoke with Pharm Exec about adding a new position to the company's C-suite.

85

85

Pharmacy Times

OCTOBER 24, 2022

In a panel, pharmacy technicians across the world discuss the different continuing educations requirements in United States, Portugal, and the United Kingdom.

93

93

pharmaphorum

OCTOBER 24, 2022

Novartis has chalked up another clinical trial win for its targeted factor B inhibitor iptacopan as it strives to position the drug as a patient-friendly, oral alternative to big-selling injectable rivals. The least positive readout comes from the APPLY-PNH study, which pitted iptacopan against AstraZeneca/Alexion’s anti-C5 antibodies Soliris (eculizumab) and Ultomiris (ravulizumab) in adults with paroxysmal nocturnal haemoglobinuria (PNH), a debilitating ultra-rare blood disorder in which

81

81

The FDA Law Blog

OCTOBER 24, 2022

By Mark A. Tobolowsky — Making use of real-world data has long been of interest to stakeholders as having tremendous potential value. These data are routinely collected from a variety of sources, such as electronic health records, providing information on health and healthcare in actual patients, rather than in the controlled environment of a clinical trial.

FDA 78

FDA Labelling 78

pharmaphorum

OCTOBER 24, 2022

With US government supplies of Covid vaccines predicted to run out in the first quarter of 2023, it has been revealed that Pfizer/BioNTech plans to charge as much as $130 for its Covid vaccine, Comirnaty, once Covid vaccines and therapeutics are moved onto commercial health platforms. According to The People’s Vaccine Alliance, Comirnaty costs an estimated $1.18 per dose to produce.

Vaccines 79

Vaccines Insurance 79

STAT

OCTOBER 24, 2022

While many Americans are familiar with the devastating impact of Alzheimer’s disease, few understand the cruel disparity with which it strikes. Black Americans are twice as likely to be diagnosed with this mind-robbing disease and bear the greatest costs of caring for loved ones suffering with it. Alzheimer’s was historically diagnosed based on symptoms, and only confirmed with an autopsy.

75

75

Digital Pharmacist

OCTOBER 24, 2022

Innovation drives progress. When it comes to innovation in the development of new drugs and therapeutic biological products in the pharmaceutical industry, the United States Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research (CDER) is a key supporter of the pharmaceutical industry. . CDER relies on its understanding of science and regulatory procedures to support and provide advice to pharmaceutical companies in testing and manufacturing, to then bring these new ther

FDA 75

FDA Adverse Reactions Pharmaceutical Companies Pharmaceutical Companies 75

European Pharmaceutical Review

OCTOBER 24, 2022

Adaflex, the UK’s first melatonin product for six to 17 year-olds diagnosed with ADHD and insomnia (where sleep hygiene measures have been inadequate), is now available in the UK. Melatonin is commonly used to treat insomnia. However until now, prescribing a treatment for children with ADHD has been off-label or unlicensed in the UK. AGB-Pharma , the Swedish pharmaceutical company that produced the drug, predicted around 60 percent of all melatonin prescriptions are dispensed to under 18s off-la

Labelling 75

Labelling Pharmaceutical Companies Pharmaceutical Companies Patient Care 75